SEARCH

SEARCH BY CITATION

References

  • 1
    Wands JR. Subacute and chronic active hepatitis after withdrawal of chemotherapy. Lancet 1975; 2: 979.
  • 2
    Galbraith RM, Eddleston ALWF, Williams R, Zuckerman AJ, Bagshawe KD. Fulminant hepatic failure in leukemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet 1975; 2: 52830.
  • 3
    Hanta T, Okita K, Matsuda S, Konishi T, Yasunaga M, Kado Y, et al. A case of fulminant hepatitis developing in a HBsAg carrier after chemotherapy of malignant lymphoma. Nippon Shokakibyo Gakkai Zasshi 1984; 81: 108993.
  • 4
    Hoofnagle JH, Dusheiko GM, Schafer DF, Jones EA, Micetich KC, Young RC, et al. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. Ann Intern Med 1982; 96: 4479.
  • 5
    Pariente EA, Goudeau A, Dubois F, Degott C, Gluckman E, Devergie A, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogenic bone marrow transplantation. Dig Dis Sci 1988; 33: 118591.
  • 6
    Bird GLA, Smith H, Portmann B, Alexander GJM, Williams R. Acute liver decompensation on withdrawal of cytotoxic chemotherapy and immunosuppressive therapy in hepatitis B carriers. Q J Med 1989; 73: 895902.
  • 7
    Pinto PC, Eddie HU, Bernstein-Singer M, Pinter-Brown L, Govindarajan S. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B. Cancer 1990; 65: 87884.
  • 8
    Liang RHS, Lok ASF, Lai CL, Chan TK, Todd D, Chiu EKW. Hepatitis B infection in patients with lymphoma. Hematol Oncol 1990; 8: 26170.
  • 9
    Lok ASF, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 1828.
  • 10
    Ohtsu T, Sai T, Oka M, Sugai Y, Tobinai K. Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies. Jpn J Clin Oncol 1991; 21: 3605.
  • 11
    Yoshiba M, Sekiyama K, Sugata F, Okamoto H, Yamamoto K, Yotsumoto S. Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment. Dig Dis Sci 1992; 37: 12539.
  • 12
    Tanaka J, Yoshizawa H. Epidemiology of hepatitis virus B and C. Igaku No Ayumi 1994; 171: 95964.
  • 13
    Robinson WS. Hepatitis B virus and hepatitis D virus. In: MandellGL, BennettJE, DolinR, editors. Mandell, Douglas and Bennett's principles and practice of infectious disease. 4th edition. New York: Churchill Livingstone Inc, 1995: 140639.
  • 14
    Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981; 81: 98791.
  • 15
    Statistics Bureau, Management and Coordination Agency. Japan statistical yearbook. 43rd edition. Tokyo: Japan Statistical Association, 1993: 668.
  • 16
    Tur-Kaspa R, Burk RD, Shaul Y, Shafrits DA. Hepatitis B virus DNA contains a glucocorticoid responsive element. Proc Natl Acad Sci USA 1986; 83: 162731.
  • 17
    Sagnelli E, Manzillo G, Maio G, Pasquale G, Felaco FM, Filippini P, et al. Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis. Lancet 1980; 2: 3957.
  • 18
    Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699704.
  • 19
    Ehata T, Omata M, Chuang WL, Yokosuka O, Ito Y, Hosoda K, et al. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis. J Clin Invest 1993; 91: 120613.
  • 20
    Liang TJ, Hasegawa K, Munoz SJ, Shapiro CN, Yoffe B, McMahon BJ, et al. Hepatitis B virus precore mutation and fulminant hepatitis in the United States. J Clin Invest 1994; 93: 5505.
  • 21
    Lee JH, Bisceglie AMDI, Baker BL, Zeldis JB. The development of a mutation in the precore region of the hepatitis B virus in a chronically infected individual. Gastroenterology 1994; 106: 2437.
  • 22
    Sato S, Suzuki K, Akahane Y, Akamatsu K, Akiyama K, Yonomura K, et al. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 1995; 122: 2418.
  • 23
    Tsujii T, Fukui H, Yoshikawa M. Etiology of chronic hepatitis. Nippon Naika Gakkai Zasshi 1994; 83: 1815.
  • 24
    Fan FS, Tzeng CH, Hsiao KI, Hu ST, Liu WT, Chen PM. Withdrawal of immunosuppressive therapy in allogenic bone marrow transplantation reactivates chronic viral hepatitis C. Bone Marrow Transplant 1991; 8: 41720.
  • 25
    Vento S, Cainelli F, Mirandola F, Cosco L, Perri GD, Solbiati M, et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347: 923.